Predictors of lung entrapment in malignant pleural effusion

医学 内科学 恶性肿瘤 胸腔积液 恶性胸腔积液 肺癌 单变量分析 逻辑回归 多元分析 胃肠病学
作者
Rita A. Trovisco,Cláudia Freitas,Mariana Serino,Pedro Magalhães Ferreira,B. Martins,David Coelho,N. Melo,Gabriela Fernandes,A. Magalhães,Hélder Novais Bastos
出处
期刊:Pulmonology [Elsevier BV]
卷期号:30 (6): 555-562 被引量:6
标识
DOI:10.1016/j.pulmoe.2022.08.001
摘要

Malignant pleural effusion (MPE) is a common complication in advanced stages of malignancy and is associated with poor prognosis. Non-expandable lung (NEL) often occurs and its presence influences the MPE approach. Our main objective was to assess risk factors for malignant NEL. Patients diagnosed with pathologically confirmed MPE between January 2012 and December 2018 in our institution were retrospectively analyzed. Demographic and clinical data of patients were reviewed and compared according to the presence or absence of NEL. A univariate and multivariate binary logistic regression analysis were used to determine predictors of the development of NEL. Of 365 patients included, 68 (18.6%) had NEL. After multivariate analysis, we found that loculated MPE (OR 8.63, 95%CI 4.30-17.33, p<0.001), complete hemithorax opacification (OR 2.81, 95%CI 1.17-6.76, p<0.021), lung cancer (OR 2.09, 95%CI 1.01-4.31, p=0.047) and higher effusion-serum LDH ratio (OR 1.09, 95%CI 1.00-1.17, p=0.039) were independent predictors of malignant NEL. There were no significant differences compared with expandable lung group regarding time from primary malignancy diagnosis to MPE diagnosis (3.0, IQR 0.0-75.8 vs 2.0, IQR 0.0-75.5 weeks, p=0.942) or MPE symptoms onset to MPE diagnosis (4.0, IQR 1.0-9.0 vs 3.0, IQR 1.0-9.0 weeks, p=0.497). Patients with NEL had a higher number of therapeutic pleural drainages (3.0, IQR 2.0-6.0 vs 2.0, IQR 1.0-3.0; p<0.001) and longer hospital stay (32.5, IQR 15.5-46.3 vs 21.0, IQR 11.0-36.0, p=0.007), measured in hospitalization days until the end of life, than patients with expandable lung. The rate of recurrence of pleural effusion was not significantly different between groups (p=0.291). Overall survival (OS) was 3.0 (95%CI, 2.3-3.7) months, regardless of lung expandability (p=0.923). Loculated MPE, complete hemithorax opacification, lung cancer and a higher effusion-serum LDH ratio were found to be independent predictors for NEL. These patients underwent thoracocenteses more frequently and had longer hospitalization days, although without significant impact in the OS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
月亮啊完成签到 ,获得积分10
3秒前
胡杨树2006完成签到,获得积分10
5秒前
健忘的晓小完成签到 ,获得积分10
5秒前
zhangxiaoqing完成签到,获得积分10
11秒前
梵高线上完成签到,获得积分10
12秒前
山山而川完成签到,获得积分10
13秒前
wtt完成签到 ,获得积分10
16秒前
YvesWang完成签到,获得积分20
19秒前
YvesWang发布了新的文献求助20
23秒前
醒了没醒醒完成签到 ,获得积分10
24秒前
clxgene完成签到,获得积分10
26秒前
没羽箭完成签到,获得积分10
28秒前
kkscanl完成签到 ,获得积分10
31秒前
春春完成签到,获得积分10
32秒前
33秒前
蓝景轩辕完成签到 ,获得积分10
38秒前
没羽箭发布了新的文献求助10
39秒前
泥嚎完成签到,获得积分10
39秒前
学生信的大叔完成签到,获得积分10
41秒前
香蕉新儿完成签到,获得积分10
44秒前
旺旺完成签到,获得积分10
48秒前
杨永佳666完成签到 ,获得积分10
55秒前
简单完成签到,获得积分10
55秒前
leilei完成签到,获得积分10
56秒前
ccc完成签到 ,获得积分10
58秒前
资格丘二完成签到 ,获得积分10
1分钟前
hj123完成签到,获得积分10
1分钟前
gincle完成签到,获得积分10
1分钟前
谦让以亦完成签到 ,获得积分10
1分钟前
钱钱钱完成签到,获得积分10
1分钟前
MRJJJJ完成签到,获得积分10
1分钟前
1分钟前
领导范儿应助wsx4321采纳,获得10
1分钟前
玖月完成签到 ,获得积分0
1分钟前
ycd完成签到,获得积分10
1分钟前
我独舞完成签到 ,获得积分10
1分钟前
飞云完成签到 ,获得积分10
1分钟前
王平安完成签到 ,获得积分10
1分钟前
FFFFF完成签到 ,获得积分0
1分钟前
源孤律醒完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6362250
求助须知:如何正确求助?哪些是违规求助? 8175899
关于积分的说明 17224379
捐赠科研通 5416933
什么是DOI,文献DOI怎么找? 2866654
邀请新用户注册赠送积分活动 1843775
关于科研通互助平台的介绍 1691562